Jean Y. Tang MD PhD
Publication Details
-
Novel investigational drugs for basal cell carcinoma.
Expert Opin Investig Drugs. 2010; (9): 1099-112
In the United States, the annual incidence of basal cell carcinoma (BCC) is close to 1 million. Ultraviolet radiation exposure is the main risk factor; however, the availability of ever more potent sunscreens and education have not prevented the rise in BCC incidence. Therefore, concerted effects to identify novel preventive and therapeutic strategies are necessary.
Help